ERBB2 and breast carcinoma: In HER2+ breast cancer, FCGRIA and FCGR2A were expressed on monocytes and macrophages (Fig. 1C), whereas in TNBC, FCGRIA and FCGR2A were expressed on monocytes, macrophages, and DCs (Fig. 1D).